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Definition 
Anaphylaxis is an acute, potentially life-threatening 
hypersensitivity reaction, involving the release of 
mediators from mast cells, basophils and recruited 
inflammatory cells. Anaphylaxis is defined by a 
number of signs and symptoms, alone or in 
combination, which occur within minutes, or up to 
a few hours, after exposure to a provoking agent. It 
can be mild, moderate to severe, or severe. Most 
cases are mild but any anaphylaxis has the potential 
to become life-threatening.1 
 
Pathogenesis 
The term anaphylaxis is often used only for a 
severe allergic reaction affecting the whole body. A 
second term, non-allergic anaphylaxis, may be used 
to describe identical reactions that are not caused by 
allergy, but involve other mechanisms in the body.1 
Mast cell activation in anaphylaxis results in 
the release of many mediators that include 
histamine, leukotrienes, tumor necrosis factor and 
various cytokines. The large numbers of mediators 
provide redundancy and positive feedback 
mechanisms whereby other effector cells are 
recruited to release more mediators, perpetuating 
the allergic response. This amplification and 
perpetuation, which has been referred to as a “mast 
cell leukocyte-cytokine cascade” underscores the 
importance of physiological antagonism with 
adrenaline and fluid resuscitation, rather than 
antagonism of a single mediator such as 
histamine.2,3 
Clinical anaphylaxis also may be due to 
mechanisms other than Ig-E mediated reactions, 
sometimes termed anaphylactoid reactions (non 
allergic anaphylaxis), including direct release of 
mediators from mast cells by medications and 
physical factors (e.g. morphine, exercise, cold), 
disturbances of leukotriene metabolism (aspirin and 
non-steroidal anti-inflammatory drugs), immune 
aggregates and complement activation (e.g. 
radiocontrast dyes and dialysis membranes).4   
 
Pathophysiology  
Anaphylactic mediators cause vasodilatation, fluid 
extravasation, smooth muscle contraction and 
increased mucosal secretions. Death may occur 
from hypoxemia (due to upper airway angioedema, 
bronchospasm and mucus plugging) and/or shock 
(due to massive vasodilatation, fluid shift into the 
extravascular space and depressed myocardial 
function).5 While compensatory tachycardia in 
response to hypotension is considered a 
characteristic feature, sudden bradycardia with 
cardiovascular collapse and cardiac arrest may 
occur before any skin features become apparent.6 
The cause of this phenomenon is unclear, but it is 
an important clinical feature to recognize in order to 
avoid making an initial misdiagnosis of a “panic 
attack” or “vasovagal reaction” in cases where 
dyspnea, nausea, anxiety, and bradycardia may 
occur just before cardiovascular collapse.3 
  
Etiology 
Food, insect venoms or medication trigger most 
cases of anaphylaxis, with a variable proportion of 
patients experiencing idiopathic anaphylaxis in 
which extensive evaluation fails to identify an 
underlying cause (Table 1). In emergency 
department studies, food allergy is the commonest 
cause in children - responsible for about 80% of 
anaphylactic reactions in which the cause has been 
identified.7  
 
Table 1. Etiology of anaphylaxis in children 
Inside the hospital: 
Latex 
Antibiotics (especially intravenous) 
Intravenous immunoglobulin 
Radiocontrast dye 
Outside the hospital: 
Food (e.g. peanut, tree nuts, shellfish, milk, egg) 
Insect sting (Hymenoptera, fire ants) 
Oral medications (e.g. penicillin) 
Exercise (including food-associated) 
Idiopathic 
Quoted from Sampson and Leung4 
 
1. IgE-mediated anaphylaxis (most common) 
Food: 
Food is one of the most common responsible 
allergens in the outpatient setting. Food allergy, 
defined as an adverse immune response to food 
proteins, affects as many as 6% of young children 
and 3% to 4% of adults and the prevalence of food-
induced anaphylaxis has been steadily rising.8, 9  
In theory, any food protein is capable of 
causing an anaphylactic reaction. Foods most 




• Peanut   
• Tree nuts (walnut, hazel nut/filbert, cashew, 
pistachio nut, Brazil nut, pine nut, almond)  
• Fish  
• Shellfish (shrimp, crab, lobster, oyster, scallops)  
• Milk (cow, goat)  
• Chicken eggs  
• Seeds (cotton seed, sesame, mustard)  
• Fruits, vegetables  
Cow's milk is one of the first foreign proteins 
ingested by infants and is one of the most common 
and potent food allergens. The presence of cow's 
milk is widespread due also to its unlabelled 
inclusion as an ingredient, or to errors in cooking, 
processing and preparation, and in restaurant food. 
As several foods may contain cow's milk in a 
hidden form, foods for allergic babies should be 
prepared at home or with food items with all their 
ingredients listed on the label.10 Contamination of 
probiotic preparations with milk allergens can cause 
anaphylaxis in children with cow's milk allergy.11 
Food sensitivity can be so severe that a 
systemic reaction can occur to particle inhalation, 
such as the odors of cooked fish or the opening of a 
package of peanuts.12,13 Contact with food may also 
cause systemic reactions.14  
A severe allergy to pollen, for example, 
ragweed, grass or tree pollen, can indicate that an 
individual may be susceptible to anaphylaxis or to 
the oral allergy syndrome (manifested primarily by 
severe oropharyngeal itching, with or without facial 
angioedema) caused by eating certain plant-derived 
foods. This is due to homologous proteins found 
between pollens and foods. The main allergen of all 
grasses is profilin, which is a pan-allergen, found in 
many plants, pollens and fruits, and grass-sensitive 
individuals can sometimes react to many plant-
derived foods. Typical allergen cross-reactivity 
associations are:1  
– Birch pollen: apple, raw potato, carrot, celery and 
hazelnut  
– Mugwort pollen: celery, apple, peanut and 
kiwifruit  
– Ragweed pollen: melons (watermelon, 
cantaloupe, honeydew) and banana  
– Latex: banana, avocado, kiwifruit, chestnut and 
papaya 
 
Antibiotics and other drugs 
Penicillin is the most common cause of 
anaphylaxis. Serious reactions to penicillin occur 
about twice as frequently following intramuscular 
or intravenous administration versus oral 
administration, but oral penicillin administration 
may also induce anaphylaxis. Muscle relaxants, 
e.g., suxamethonium, alcuronium, vecuronium, 
pancuronium and atracurium, which are widely 
used in general anesthesia, account for 70-80% of 
all allergic reactions occurring during general 
anesthesia. Reactions are caused by an immediate 
IgE-mediated hypersensitivity reaction.1 Drugs that 




Table 2. Drugs frequently implicated in allergic 
drug reactions 
Aspirin (other analgesics-antipyretics) 








Anesthetics (local and general) 
Phenolphthalein 
Antipsychotic tranquilizers 
Antihypertensive agents (hydralazine) 
Antiarrhythmia agents (quinidine, procainamide) 
Iodinated contrast media 
Antisera and vaccines 
Organ extracts (ACTH, insulin) 




Quoted from Thong et al 15 
 
Insects 
Hymenoptera venoms (bee, wasp, yellow-jacket, 
hornet, fire ant) contain enzymes such as 
phospholipases and hyaluronidases as well as other 
proteins which can elicit an IgE antibody response.1 
 
Latex 
Latex is a milky sap produced by the rubber tree 
Hevea brasiliensis. Latex-related allergic reactions 
can complicate medical procedures, e.g., internal 
examinations, surgery, and catheterization. Medical 
and dental staff may develop occupational allergy 
through use of latex gloves.1  
 
Foreign proteins 
Examples of foreign proteins which can cause 
anaphylaxis are insulin, seminal proteins, and 
horse-derived antitoxins, such as those used to 
neutralize venom in snake-bites.1  
 
Anaphylaxis in children 
49 
Elective medical procedures 
Allergen immunotherapy is an example. Based on 
the literature, the risk of fatality due to skin prick 
tests (SPT) is extremely remote, and 
severe/anaphylactic reactions are rare.1 
Nevertheless, this risk cannot be completely 
excluded, especially in highly susceptible subjects. 
In general, the risk of systemic reactions is lower 
with SPT than with intradermal testing. Some 
patients (history of previous anaphylactic reactions, 
small children, pregnant women, uncontrolled 
asthma, and high degree of reactivity) should be 
considered at higher risk of systemic/anaphylactic 
reactions from SPT.16  
  
2. Cytotoxic and immune complex-mediated 
reactions 
One of the mechanisms responsible for 
anaphylactic responses that follow the 
administration of whole blood or its products is the 
formation of antigen-antibody reactions on the red 
blood cell surface or from immune complexes 
resulting in the activation of complement. The 
active by-products generated by complement 
activation (anaphylatoxins C3a, C4a and C5a) cause 
mast cell (and basophil) degranulation, mediator 
release and generation, and anaphylaxis. In 
addition, complement products may directly 
increase vascular permeability and contract smooth 
muscle. Selective IgA deficient subjects (1:500 of 
the general population) can develop anaphylaxis 
when given blood products, because of their IgE 
anti-IgA antibodies. Cytotoxic reactions can also 
cause anaphylaxis, via complement activation. 
Antibodies (IgG and IgM) against red blood cells, 
as occurs in a mismatched blood transfusion 
reaction, activate complement. This reaction causes 
agglutination and lysis of red blood cells and 
perturbation of mast cells resulting in anaphylaxis.1  
 
3. Non-immunologic mast cell activators 
Hyperosmolar iodinated contrast media may cause 
mast cell degranulation by activation of the 
complement and coagulation systems. These 
reactions can still occur, but much less commonly, 
with the newer contrast media agents. Narcotics are 
mast cell activators capable of causing elevated 
plasma histamine levels and non-allergic 
anaphylaxis.1  
 
4. Modulators of arachidonic acid metabolism 
These can lead to non-IgE mediated systemic 
reactions due to overproduction of leukotrienes. IgE 
antibodies against aspirin and other NSAIDs (e.g. 
ibuprofen, indomethacin and others) have not been 
identified. Affected individuals tolerate choline or 
sodium salicylates, substances closely structurally 
related to aspirin but different in that they lack the 
acetyl group.1  
 
5. Sulfiting Agents 
Preservatives (e.g. Sodium and potassium sulfites, 
bisulfites, metabisulfites, and gaseous sulfur 
dioxides) are converted in the acid environment of 
the stomach to SO2 and H2SO3, which are then 
inhaled. They can produce asthma and non-allergic 
hypersensitivity reactions in susceptible 
individuals.1  
 
6. Idiopathic Causes 
Exercise-induced anaphylaxis can occur during the 
pollinating season of plants to which the individual 
is allergic. Catamenial anaphylaxis is a syndrome of 
hypersensitivity induced by endogenous 
progesterone secretion. Patients may exhibit a 
cyclic pattern of attacks during the premenstrual 
part of the cycle. Moreover, flushing, tachycardia, 
angioedema, upper airway obstruction, urticaria and 
other signs and symptoms of anaphylaxis can occur 
without a recognizable cause.1 
  
Cofactor induced anaphylaxis 
Cofactors are sometimes required before an allergen 
will provoke a reaction. Factors associated with 
increased risk of anaphylaxis include intercurrent 
infection, concomitant medication/food 
(particularly α-blockers, β-blockers, angiotensin-
converting enzyme [ACE] inhibitors, non-steroidal 
anti-inflammatory drugs [NSAIDS], alcohol or 
spicy food), high ambient temperature and exercise. 
So-called “summation anaphylaxis” may explain 
intermittent anaphylaxis despite frequent allergen 
exposure, and may account for some cases in which 
a cause has not been established. One of the most 
common cofactors, predominantly affecting young 
adults, is physical exercise. Some experience 
symptoms with exercise alone; others do so only if 
allergenic foods (most commonly wheat, celery, 
seafood, nuts, fruit or vegetables) are ingested 
within a few hours prior to exercise.3 It may occur 
when individuals exercise within 2-4 hours after 
ingesting a specific food. The individual is, 
however, able to exercise without symptoms, as 
long as the incriminated food is not consumed 
before exercise. The patient is likewise able to 
ingest the incriminated food with impunity as long 
as no exercise occurs for several hours after eating 






The onset of symptoms varies depending on the 
cause; reactions from ingested allergens are delayed 
in onset (minutes to 2 hours) compared with 
injected allergens and tend to have more 
gastrointestinal symptoms.4 A few or all of the 
following symptoms, often developing in this order, 
may be experienced:1 
• Itching of the lips, tongue and palate 
• swelling of the lips, tongue and throat  
• Swelling of the eyelids with itchy watery eyes  
• Generalized itching, flushing, swelling of the 
skin, and hives (urticaria)  
• Increased heart rate  
• Abdominal cramps, nausea, vomiting, diarrhea  
• Difficulty in breathing due to throat swelling, 
wheezing and asthma  
• A sense of impending doom  
• Collapse, loss of consciousness, weakness and 
faintness caused by a drop in blood pressure.  
Cutaneous symptoms may be totally absent. 
The acute onset of severe bronchospasm in an 
asthmatic should suggest the diagnosis. Some 
degree of obstructive laryngeal edema is typically 
encountered with severe reactions.4 Death may 
occur within minutes, but rarely has been reported 
to occur days to weeks after the initial anaphylactic 
event.1 
Anaphylaxis can follow a biphasic course. 
Biphasic reactivity was reported with an incidence 
of 19.4%. The second-phase onset may be 8-10 
hours on average, but it occurred as late as 38 
hours. Biphasic anaphylaxis may be related, in part, 
to under treatment.17 Protracted anaphylaxis may 
occur, with symptoms persisting for days.1 
 
Differential Diagnosis 
• Vasovagal reactions  
• Globus hystericus  
• Status asthmaticus  
• Foreign body aspiration  
• Pulmonary embolism  
• Epiglottitis  
• Myocardial infarction  
• Carcinoid syndrome  
• Hereditary angioedema  
• Pheochromocytoma  
• Hypoglycemia  
• Seizures  
• Overdose of medication  
• Cold urticaria  
• Cholinergic urticaria  
• Sulfite or monosodium glutamate ingestion 
 
Upper airway obstruction, bronchospasm, 
abdominal cramps, pruritus, urticaria and 
angioedema are absent in vasovagal reactions. 
Pallor, syncope, diaphoresis and nausea usually 
indicate a vasovagal reaction but may occur in 
either condition. If a reaction occurs during a 
medical procedure it is important to consider a 




• In-vitro testing for allergen-specific IgE is a 
useful initial screening test for a variety of 
allergens. It however lacks sensitivity and is 
limited by the range of allergens available.3 
• Skin prick tests are more sensitive than in-vitro 
testing. As these carry a small risk of inducing 
anaphylaxis, they should only be carried out in an 
environment in which resources for treating 
anaphylaxis are available.3  
• Some drug reactions (e.g. to NSAIDS, 
radiographic contrast agents) are independent of 
IgE, and there are numerous difficulties in 
assessing some cases of antibiotic allergy. To 
establish a diagnosis in cases in which the 
causative agent is in doubt, challenge testing 
under controlled conditions may sometimes be 
required, although a negative challenge test does 
not always exclude the diagnosis.3 
• Plasma histamine is elevated for a brief period but 
is unstable and difficult to measure in a clinical 
setting.4 
• Plasma beta-tryptase is more stable and remains 
elevated for several hours but is usually not 





The following steps are recommended: 6 
• Place the patient in the supine position (or left 
lateral position for vomiting patients); 
• Give intramuscular adrenaline; 
• Resuscitate with intravenous saline (20 ml/kg 
body weight, repeated up to a total of 50 ml/kg 
over the first half hour); 
• Support the airway and ventilation; and 
• Give supplementary oxygen. 
 
Intramuscular 1: 1000 (1 mg/ml) adrenaline at a 
dose of 0.01 mg/kg (0.01 ml/kg) body weight up to 
a maximum dose of 0.5 mg (0.5 ml) injected into 
the lateral thigh (vastus lateralis) has the advantage 
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that it can be given without delay, is absorbed more 
reliably than injections into other locations or 
subcutaneously, is effective in most cases when 
given early, and avoids the potentially lethal effects 
of large intravenous bolus injections. The 
appropriate dose of epinephrine injector pen 
(EpiPen) can be used instead, if available. The 
intramuscular dose can be repeated after 3–
5 minutes if required.3 
The appropriate clinical use of epinephrine has 
been limited by misconceptions and by the 
reluctance of some patients and physicians to use 
this medication. Some of these misconceptions 
include: (1) a severe attack will always be preceded 
by an earlier and milder warning reaction; (2) there 
is always time to get medical attention so patients 
do not have to worry about administering 
epinephrine so quickly; and (3) medications, 
especially epinephrine, will always work when 
needed, even if use is delayed by patients who wait 
and see whether they will really need it. In fact, 
milder warning attacks will not necessarily precede 
a fatal or near-fatal reaction. It is also clear that 
some of these reactions progress so rapidly that 
there is not enough time to obtain medical 
attention.18 
If resuscitation using intramuscular adrenaline 
and volume expansion with intravenous saline is 
ineffective, an infusion of intravenous adrenaline 
may be required, but this should be done only by 
experienced hands. Intravenous boluses of 
adrenaline are potentially dangerous and should not 
be used unless cardiac arrest is imminent5. 
Controlled intravenous infusions of adrenaline were 
shown to be safe and effective in one prospective 
study.6 
If the patient is still unresponsive after the 
treatments outlined above, there are several further 
options:3 
• Persistent bronchospasm may respond to 
treatment with additional bronchodilators. If 
intubation is required, continuous puffs of 
salbutamol through an aerosol port directly into 
the ventilation circuit may help to “break” severe 
bronchospasm. 
• Persistent stridor may respond to continuous 
nebulised adrenaline (5 mg in 5 ml [i.e. five 1 mg 
ampoules]) in addition to parenteral adrenaline. 
Surgical airway intervention (cricothyrotomy) 
may be required. 
• Persistent hypotension may be due to either 
profound vasodilatation or cardiac failure. 
Anecdotally, vasodilatation may respond to 
vasopressors such as metaraminol or vasopressin. 
In patients who have pre-existing heart failure or 
are taking β-blockers, a phosphodiesterase 
inhibitor such as glucagon may be tried.19,20 
 
The World Allergy Organization (WAO) 
recommends a simple ABC action plan1 for 
treatment of anaphylaxis displayed on its website 
(www. worldallergy. org) in the Allergic Diseases 
Resource Center (Table 3)    
 
Long-term management of individuals who have 
experienced anaphylaxis: 1,4 ,21-23 
• Agents causing anaphylaxis should be identified 
when possible and avoided. Patients and their 
care-givers should be instructed how to minimize 
exposure including reading food labels and early 
recognition of anaphylactic symptoms  
• Beta-adrenergic antagonists, including those used 
to treat glaucoma, may exacerbate anaphylaxis 
and should be avoided, whenever possible.  
• Individuals at high risk for anaphylaxis should be 
issued epinephrine syringes for self-
administration and instructed in their use. Patients 
must be alerted to the clinical signs of impending 
anaphylaxis and the need to use epinephrine at the 
earliest onset of symptoms. Unused syringes 
should be replaced immediately when they reach 
their use-by/expiration date, as epinephrine 
content and bioavailability of the drug decreases 
in proportion to the number of months past the 
expiration date. 
• Children and their care-givers should be offered a 
written emergency plan in case of accidental 
ingestion. They should be reminded that they 
cannot depend on an oral antihistamine or an 
asthma inhaler in anaphylaxis, and should be 
equipped with accurate medical identification and 
a practical anaphylaxis emergency action plan. 
• Pre-treatment with glucocorticosteroids and H1 
and H2 antihistamines is recommended to prevent 
or reduce the severity of a reaction where it is 
medically necessary to administer an agent 
known to cause anaphylaxis, e.g., radio-contrast 
media. 
• Patients with egg allergy should be tested before 
receiving measles, influenza or yellow fever 
vaccines which contain egg protein. 
• Children who experienced systemic anaphylactic 
reactions to an insect sting should be evaluated 
and treated with specific immunotherapy which is 
more than 90% protective. 
• In cases of food-associated exercise-induced 
anaphylaxis, children must not exercise within 2-
3 hours of ingesting the triggering food and 
should not exercise alone and should learn to 
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recognize the early signs of anaphylaxis 
(sensation of warmth and facial pruritis). 
• Reactions to medications can be reduced and 
minimized by using oral medications in 
preference to injected forms. 
• New hypo-osmolar radiocontrast dyes can be 
used in cases where previous reactions are 
suspected. 
• The use of powder-free, low allergen gloves and 
materials should be used in children undergoing 
multiple surgeries. 
• Verification of the trigger should be sought by 
obtaining a comprehensive history of the 
anaphylaxis episode and performing relevant 
investigations, as well as determining co-
morbidities and concomitant medications.  
• Anaphylaxis education should be provided for 
individuals at risk, their families and caregivers, 




Table 3. ABC in the treatment of anaphylaxis 
Emergency treatment of anaphylaxis 
A = Airway 
– Ensure and establish a patent airway by repositioning the head and neck, endotracheal intubation or emergency 
cricothyrotomy.  
– Place the patient in a supine position and elevate the lower extremities.  
– Patients in severe respiratory distress may be more comfortable in the sitting position.  
B = Breathing 
– Assess adequacy of ventilation and provide the patient with sufficient oxygen with an oxygen saturation of at 
least 91% as determined by pulse oximetry.  
– Treat bronchospasm as necessary.  
– Equipment for endotracheal intubation should be available for immediate use in event of respiratory failure and 
is indicated for poor mentation, respiratory failure, or stridor not responding immediately to supplemental 
oxygen and epinephrine.  
C = Circulation  
– Minimize or eliminate continued exposure to the causative agent by discontinuing the infusion, as with radio-
contrast media, or by placing a venous tourniquet proximal to the site of the injection or insect sting.  
– Assess adequacy of perfusion by taking the pulse rate, blood pressure, mentation and capillary refill time.  
– Establish IV access with large bore (16 to 18 gauges) catheter and administer an isotonic solution such as 
normal saline.  
– If a vasopressor, such as dopamine becomes necessary, the patient requires immediate transfer to an intensive 
care setting.  
Pharmacologic management of anaphylaxis:  
A = Adrenalin = epinephrine 
– Epinephrine is the drug of choice for anaphylaxis. It stimulates both the beta-and alpha-adrenergic receptors and 
inhibits further mediator release from mast cells and basophils.  
– The dose for children is 0.01 mg/kg to a maximum of 0.3 mg intramuscularly every 5-30 minutes as necessary. 
Lower doses, e.g., 0.1 mg to 0.2 mg administered intramuscularly as necessary, are usually adequate to treat 
mild anaphylaxis, often associated with skin testing or immunotherapy.  
– Epinephrine should be given early in the course of the reaction and the dose titrated to the clinical response.  
– For a severe hypotension, 1 cc of a 1:10,000 w/v dilution of epinephrine given slowly intravenously is indicated. 
The patient's response determines the rate of infusion.  
B = Benadryl (diphenhydramine)  
– Antihistamines are not useful for the initial management of anaphylaxis but may be helpful once the patient 
stabilizes. Cimetidine offers the theoretical benefit of reducing both histamine-induced cardiac arrhythmias, 
which are mediated via H2 receptors, and anaphylaxis-associated vasodilatation, mediated by H1 and H2 
receptors.   
C = Corticosteroids 
– Corticosteroids do not benefit acute anaphylaxis but may prevent relapse or protracted anaphylaxis. 
Hydrocortisone or its equivalent can be administered every 6 to 8 hours for the first 24 hours. 
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Table 4. Anaphylaxis avoidance strategies in schools and child-care settings  
- Food avoidance 
• School or nursery staff should know the technical and scientific words for common foods. 
• Ingredient statements should be carefully read before giving the child any food.  
• Strict “no food or eating-utensil trading” rules should be implemented throughout the school to avoid peer 
pressure.  
• Surfaces (e.g., tables and toys) should be washed clean of contaminating foods.  
• The food used in lesson plans and cooking classes may need to be substituted depending on the allergies of the 
students.  
• Hand washing after food handling should be encouraged in day care and preschool settings. 
• Airborne food clinical reactions have been documented. Thus, preparing or cooking the food in the presence of 
the allergic student should be avoided. 
• If a student is going to eat from the cafeteria menu, the child’s parents should inform the staff in writing about 
foods to be avoided and suggest “safe” substitutions.  
• Food service personnel should also be instructed about measures necessary to prevent cross contact during the 
handling, preparation, and serving of food.  It should be stressed that minute amounts of certain foods, such as 
peanuts, can be life-threatening when ingested  
• Foods brought in for special events should contain complete ingredient declarations. 
• Education and supervision are paramount and guidelines for children should include the following: (1) no trading 
or sharing of foods, food utensils, and food containers, and (2) hand washing should be encouraged before and 
after eating.  
- Insect avoidance: 
• Insect nests should be removed from on or near school property 
• Garbage should be properly placed in well-covered containers 
• Eating areas should be restricted to inside school buildings for students and staff at risk.  
- Other allergies: 
• Anaphylaxis caused by drug and latex allergies is rare in the school setting. These should be dealt with on an 
individual basis. 




1. Lockey RF. Anaphylaxis: Synopsis. World Allergy 
Organization Allergic Diseases Resource Center: 
information for health professionals. Last modified 
on April 28, 2006; accessed on July 28, 2007. 
Available at http://www.worldallergy.org/ 
professional/allergic_diseases_center/anaphylaxis/an
aphylaxissynopsis.shtml 
2. Williams CM, Galli SJ. The diverse potential 
effector and immunoregulatory roles of mast cells in 
allergic disease. J Allergy Clin Immunol 2000; 
105(5): 847-59.  
3. Brown SG, Mullins RJ, Gold MS. Anaphylaxis: 
diagnosis and management. Med J Aust 2006; 185 
(5): 283-9. 
4. Sampson HA, Leung DYM. Anaphylaxis. In: 
Behrman RE, Kliegman RM, Jenson HB, editors. 
Nelson textbook of pediatrics. 17th edn. 
Philadelphia: WB Saunders; 2004.p.781-2. 
5. Brown SG. Anaphylaxis: clinical concepts and 
research priorities. Emerg Med Australas 2006; 
18(2): 155-69.  
6. Brown SGA, Blackman KE, Stenlake V, Heddle 
RJ. Insect sting anaphylaxis; prospective evaluation 
of treatment with intravenous adrenaline and volume 
resuscitation. Emerg Med J 2004; 21(2): 149-54 
7. Braganza SC, Acworth JP, McKinnon DR, 
Peake JE, Brown AF. Paediatric emergency 
department anaphylaxis: different patterns from 
adults. Arch Dis Child 2006; 91(2): 159-63. 
8. Sicherer SH, Sampson HA. 9. Food allergy. J 
Allergy Clin Immunol 2006; 117(2 Suppl Mini-
Primer): S470-5. 
9. Wang J, Sampson HA. Food anaphylaxis. Clin Exp 
Allergy 2007; 37(5): 651-60. 
10. Cantani A. Hidden presence of cow's milk proteins 
in foods. J Investig Allergol Clin Immunol 1999; 
9(3): 141-5. 
11. Lee TT, Morisset M, Astier C, Moneret-Vautrin 
DA, Cordebar V, Beaudouin E, et al. 
Contamination of probiotic preparations with milk 
allergens can cause anaphylaxis in children with 




12. Sicherer SH, Furlong TJ, DeSimone J, 
Sampson HA. Self-reported peanut allergic 
reactions on commercial airlines. J Allergy Clin 
Immunol 1999; 104(1):186-9. 
13. James JM, Crespo JF. Allergic reactions to foods 
by inhalation. Curr Allergy Asthma Rep 2007; 7(3): 
167-74. 
14. Bahna SL. Adverse food reactions by skin contact. 
Allergy 2004; 59 Suppl 78: 66-70 
15. Thong B, Motala C, Vervloet D. Drug Allergies. 
World Allergy Organization Allergic Diseases 
Resource Center: information for health 
professionals. Last modified on February 1, 2007; 




16. Liccardi G, D'Amato G, Canonica GW, Salzillo 
A, Piccolo A, Passalacqua G. Systemic reactions 
from skin testing: literature review. J Investig 
Allergol Clin Immunol 2006; 16(2): 75-8. 
17. Ellis AK, Day JH. Incidence and characteristics of 
biphasic anaphylaxis: a prospective evaluation of 



















18. AAAAI Position Statement. The use of epinephrine 
in the treatment of anaphylaxis, November 2002; 
accessed on July 28, 2007. Available at http: 
//www.aaaai.org/media/resources/academy_stateme
nts/position_statements/ps26.asp 
19. Schummer W, Schummer C, Wippermann J, 
Fuchs J. Anaphylactic shock: is vasopressin the 
drug of choice? Anesthesiology 2004; 101(4): 1025-
7. 
20. Thomas M, Crawford I. Best evidence topic report. 
Glucagon infusion in refractory anaphylactic shock 
in patients on beta-blockers. Emerg Med J 2005; 
22(4): 272-3. 
21. Joint Task Force on Practice Parameters, American 
Academy of Allergy, Asthma, and Immunology, 
American College of Allergy, Asthma, and 
Immunology, Joint Council of Allergy Asthma and 
Immunology. The diagnosis and management of 
anaphylaxis: an updated practice parameter. J 
Allergy Clin Immunol 2005; 115(3 Suppl 2): S483-
523. 
22. Simons FE. Anaphylaxis, killer allergy: long-term 
management in the community. J Allergy Clin 
Immunol 2006; 117(2): 367-77. 
23. AAAAI Position Statement. Anaphylaxis in 
schools and other child-care settings, August 1998; 
accessed on July 29, 2007. Available at 
http://www.aaaai.org 
/media/resources/academy%5Fstatements/position_s
tatements/ps34.asp 
